RE:RE:RE:RE:RE:RE:RE:RE:Skinmedica even&correctI agree on the timing of the number of months to launch this based upon the typical 18 month ramp up period to put it out on the shelves, January 2023 seems to appear way too early and the compound name would need to be listed on the product label which someone pointed out it is not- probably the only two kernels of wisdom picked up from the R&F launch experience.
There is also the question around the plans for global rollout. They may in fact be tackling various markets differently.
It would be a good question though to raise for the Q&A in the context of general timing of when, where, and how the 1067 goes live.